搜尋結果
Opinion | The Making of an American Radical
The Wall Street Journal· 8 小時前The career of Calla Walsh is a window on Palestine Action US, which wants to disrupt the ...
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 8 小時前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 9 小時前, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug ...
The fight over Fisker's assets is already heating up
TechCrunch· 9 小時前Fisker is just a few days into its Chapter 11 bankruptcy, and the fight over its assets is ...
Arrests at Euro 2024 in Berlin after trouble involving "mostly Polish" fans
Reuters· 9 小時前Berlin police said on Friday they had made arrests after an altercation involving "mostly ...
Fact Check: NASA did not abruptly stop deep-sea research
Reuters· 9 小時前The National Aeronautics and Space Administration (NASA) did not abruptly end its deep-sea ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 9 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 10 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Wall St Week Ahead Rally in U.S. big tech stocks may be getting stretched
Reuters· 10 小時前A blistering rally in U.S. big tech stocks may be due for a breather, offering hope for market ...
Securities are in the eye of the beholder
TechCrunch· 10 小時前The U.S. Securities and Exchange Commission has brought down its wrath on Coinbase. The publicl ...